ISB-1442

N/A

Report date: 2025/01/18 20:00:05

Base Information

Drug NameISB-1442

Drug Alias NameISB 1442ISB-1442

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 47 inhibitorsAnti-CD38

TargetsCluster of differentiation 47Lymphocyte differentiation antigen CD38

Therapy Area/IndicationsMultiple MyelomaLeukemia, Myeloid, AcutePrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustraliaIndia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIchnos Sciences Sa

China Registration ClassN/A

Develop Information

Active CompaniesIchnos Sciences Sa

Inactive CompaniesN/A

Active IndicationsMultiple MyelomaLeukemia, Myeloid, AcutePrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A